메뉴 건너뛰기




Volumn 42, Issue 11, 2003, Pages 1425-1426

Anti-TNF treatment in secondary amyloidosis [9]

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR;

EID: 0242524604     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg361     Document Type: Letter
Times cited : (23)

References (8)
  • 1
    • 0027438710 scopus 로고
    • Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha
    • Elliott MJ, Maini RN, Feldmann M et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993;36:1681-90.
    • (1993) Arthritis Rheum. , vol.36 , pp. 1681-1690
    • Elliott, M.J.1    Maini, R.N.2    Feldmann, M.3
  • 2
    • 0034735842 scopus 로고    scopus 로고
    • Infliximab and methotrexate in the treatment of rheumatoid arthritis
    • Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant Therapy Study Group
    • Lipsky PE, van der Heijde DMFM, St Clair EW et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant Therapy Study Group. N Engl J Med 2000;343:1594-602.
    • (2000) N. Engl. J. Med. , vol.343 , pp. 1594-1602
    • Lipsky, P.E.1    van der Heijde, D.M.F.M.2    St Clair, E.W.3
  • 3
    • 0036183028 scopus 로고    scopus 로고
    • Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: One year follow up
    • Kruithof E, Van der Bosch F, Baeten D, Herssens A et al. Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. Ann Rheum Dis 2002;61:207-12.
    • (2002) Ann. Rheum. Dis. , vol.61 , pp. 207-212
    • Kruithof, E.1    Van der Bosch, F.2    Baeten, D.3    Herssens, A.4
  • 4
    • 0036201966 scopus 로고    scopus 로고
    • Tumor necrosis factor (TNF) in psoriatic arthritis: Pathophysiology and treatment with TNF inhibitors
    • Mease PJ. Tumor necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors. Ann Rheum Dis 2002;61:298-304.
    • (2002) Ann. Rheum. Dis. , vol.61 , pp. 298-304
    • Mease, P.J.1
  • 5
    • 0000134946 scopus 로고    scopus 로고
    • Etanercept in Wegener's granulomatosis: A six month open-label trial to evaluate safety
    • Stone J, Uhlfelder M, Hellmann D, Crook S, Bedocs N, Hoffman G. Etanercept in Wegener's granulomatosis: a six month open-label trial to evaluate safety. Arthritis Rheum 2000; 43 (Suppl.) : S404.
    • (2000) Arthritis Rheum. , vol.43 , Issue.SUPPL.
    • Stone, J.1    Uhlfelder, M.2    Hellmann, D.3    Crook, S.4    Bedocs, N.5    Hoffman, G.6
  • 6
    • 0036093131 scopus 로고    scopus 로고
    • Etanercept in the treatment of adults patients with Still's disease
    • Husni ME, Maier AL, Mease PJ et al. Etanercept in the treatment of adults patients with Still's disease. Arthritis Rheum 2002;46:1171-6.
    • (2002) Arthritis Rheum. , vol.46 , pp. 1171-1176
    • Husni, M.E.1    Maier, A.L.2    Mease, P.J.3
  • 7
    • 0025936525 scopus 로고
    • Secondary systemic amyloidosis: Response and survival in 64 patients
    • Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 1991;70:246-56.
    • (1991) Medicine (Baltimore) , vol.70 , pp. 246-256
    • Gertz, M.A.1    Kyle, R.A.2
  • 8
    • 0036198146 scopus 로고    scopus 로고
    • Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis
    • Singh R, Cuchacovich R, Huang W, Espinoza LR. Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis. J Rheumatol 2002;29:636-7.
    • (2002) J. Rheumatol. , vol.29 , pp. 636-637
    • Singh, R.1    Cuchacovich, R.2    Huang, W.3    Espinoza, L.R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.